KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Jazz Pharmaceuticals (JAZZ) EPS (Weighted Average and Diluted): 2009-2025

Historic EPS (Weighted Average and Diluted) for Jazz Pharmaceuticals (JAZZ) over the last 15 years, with Sep 2025 value amounting to $4.08.

  • Jazz Pharmaceuticals' EPS (Weighted Average and Diluted) rose 19.30% to $4.08 in Q3 2025 from the same period last year, while for Sep 2025 it was $8.98, marking a year-over-year increase of 26.30%. This contributed to the annual value of $8.65 for FY2024, which is 41.80% up from last year.
  • According to the latest figures from Q3 2025, Jazz Pharmaceuticals' EPS (Weighted Average and Diluted) is $4.08, which was up 364.94% from -$1.54 recorded in Q2 2025.
  • Over the past 5 years, Jazz Pharmaceuticals' EPS (Weighted Average and Diluted) peaked at $4.08 during Q3 2025, and registered a low of -$6.11 during Q2 2021.
  • For the 3-year period, Jazz Pharmaceuticals' EPS (Weighted Average and Diluted) averaged around $1.74, with its median value being $1.83 (2023).
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first tumbled by 611.11% in 2022, then skyrocketed by 3,366.67% in 2023.
  • Over the past 5 years, Jazz Pharmaceuticals' EPS (Weighted Average and Diluted) (Quarterly) stood at -$0.54 in 2021, then crashed by 611.11% to -$3.84 in 2022, then surged by 137.24% to $1.43 in 2023, then spiked by 111.19% to $3.02 in 2024, then rose by 19.30% to $4.08 in 2025.
  • Its last three reported values are $4.08 in Q3 2025, -$1.54 for Q2 2025, and $3.02 during Q4 2024.